Bhagiradha chemicals & industries Limited has announced a board meeting scheduled for February 10, 2026, to consider and approve the company's unaudited financial results for the third quarter of fiscal year 2026. The meeting will be held at the company's Hyderabad office to transact important business items as per the regulatory requirements.

Board Meeting Agenda

The board meeting has been convened in accordance with Regulation 29, 33 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting agenda includes two primary items for consideration:

Trading Window Closure

In compliance with regulatory requirements, the company has implemented a trading window closure for all designated persons and their immediate relatives. The restrictions are effective under the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal Code of Conduct for prevention of insider trading.

Regulatory Compliance

The company has formally notified both BSE Limited and National Stock Exchange of India Limited about the scheduled board meeting through official communication dated January 30, 2026. The notification was signed by Sharanya M, Company Secretary & Compliance Officer, ensuring proper adherence to stock exchange listing requirements.

The meeting represents a standard quarterly review process where the board will evaluate the company's financial performance for the third quarter and nine-month period ending December 31, 2025. The results will provide stakeholders with insights into the company's operational and financial performance during this period.

Bhagiradha Chemicals & Industries Limited has issued a clarification to BSE Limited regarding a recent surge in trading volume of its securities, responding to a surveillance inquiry dated December 19, 2025.

BSE Surveillance Inquiry Response

The company received a communication from BSE Surveillance (Volume Movement Letter No. L/SURV/ONL/PV/APJ/2025-2026/781) seeking clarification on the significant increase in trading volume across exchanges. In its formal response, Bhagiradha Chemicals emphasized its adherence to regulatory disclosure requirements.

Regulatory Compliance Statement

The company confirmed its commitment to disclosing all material events and price-sensitive information to stock exchanges in a timely manner. Management stated that all disclosures are made as per requirements of Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 and other applicable laws.

Bhagiradha Chemicals specifically clarified that there are no material events or information pending disclosure or announcement that would require communication to stock exchanges under the current regulatory framework.

Market-Driven Volume Attribution

The management attributed the recent volume surge to market-driven factors rather than any undisclosed corporate developments. The company emphasized that the increased trading activity in its scrip across exchanges is purely due to market dynamics and not related to any pending announcements or material events.

Corporate Information

The response was signed by Sharanya M, Company Secretary and Compliance Officer (Membership No: ACS-63438), highlighting the company's structured approach to regulatory compliance and investor communication.